Roche News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.01.22	Roche: FDA Approves Vabysmo To Treat Two Vision-threatening Retinal Conditions (RTTNews)
24.01.22	Genentech's Faricimab Improved, Maintained Vision In Two Causes Of Vision Loss (RTTNews)
12.01.22	Roche Launches Cobas Pulse System In Select Countries - Quick Facts (RTTNews)
11.01.22	Roche Unveils Cobas Infinity Edge, Digital Ecosystem For Point Of Care Professionals (RTTNews)
27.12.21	Biotech Stocks Facing FDA Decision In January 2022 (RTTNews)
26.12.21	Roche COVID-19 At-Home Test Granted FDA Emergency Use Authorization (RTTNews)
20.12.21	Why Lineage Cell Therapeutics Is Rising In Pre-market? (RTTNews)
17.12.21	Roche Gets CE Mark For Use Of Saliva Samples With Cobas SARS-CoV-2 Qualitative Test (RTTNews)
17.12.21	Roche receives CE mark for the use of saliva samples with cobas SARS-CoV-2 Qualitative test on cobas 6800/8800 Systems (PR Newswire)
15.12.21	Roche launches the first infectious disease tests and cobas omni Utility Channel for use on the cobas 5800 System in countries accepting the CE Mark (PR Newswire)
14.12.21	Genentech's Polivy Combination Reduces Risk Of Disease Worsening Or Death By 27% In DLBCL (RTTNews)
11.12.21	Genentech : Phase I/II Result Shows Mosunetuzumab Induces Complete Response Rates In Blood Cancer (RTTNews)
10.12.21	Roche Posts Encouraging Follow-up Data From Phase II CITYSCAPE Trial - Quick Facts (RTTNews)
09.12.21	Roche : Novel Approach To Be Launched In Quebec To Study Causes And Consequences Of COVID-19 (RTTNews)
07.12.21	Recursion Announces Collaboration With Roche, Genentech In Neuroscience And Oncology (RTTNews)
07.12.21	EC Approves Roche's Tocilizumab To Treat Patients With Severe Covid-19 (RTTNews)
07.12.21	Roche Introduces AI-based Research Use Only Algorithms Developed For Breast Cancer (RTTNews)
07.12.21	Roche announces the release of its newest artificial intelligence based digital pathology algorithms to aid pathologists in evaluation of breast cancer markers, Ki-67, ER and PR (PR Newswire)
06.12.21	Roche : CHMP Recommends EU Approval Of Actemra/RoActemra To Treat Severe COVID-19 (RTTNews)
06.12.21	Roche To Launch New Test Kits To Detect, Differentiate Between Covid-19 And Influenza Viruses (RTTNews)
18.11.21	Roche Launches New Molecular Diagnostics System Cobas 5800 (RTTNews)
04.11.21	Novartis To Sell 53.3 Mln Roche Shares To Roche For $20.7 Bln (RTTNews)
28.10.21	Roche, Zur Rose Collaborate To Improve Everyday Therapy Management For People Living With Diabetes (RTTNews)
22.10.21	Roche's VENTANA PD-L1 Assay Gets FDA Approval As Companion Diagnostic For Tecentriq In NSCLC (RTTNews)
20.10.21	Roche Q3 Group Sales Rise; Lifts FY21 Outlook - Quick Facts (RTTNews)
18.10.21	Roche Adds Ibex's Image Analysis Tools To Its NAVIFY Digital Pathology Menu - Quick Facts (RTTNews)
18.10.21	Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care (PR Newswire)
16.10.21	FDA Approves Roche's Tecentriq As Adjuvant Treatment For Early Non-small Cell Lung Cancer (RTTNews)
15.10.21	Roche, PathAI To Develop AI-powered Embedded Image Analysis Workflow For Pathologists (RTTNews)
14.10.21	Genentech: Enspryng Reduces Debilitating Relapses In Neuromyelitis Optica Spectrum Disorder (RTTNews)
14.10.21	Roche To Launch Short Duration Infusion Gazyvaro For Patients In The EU - Quick Facts (RTTNews)
13.10.21	Roche: Long-term Data Reinforces Benefit Of Early Initiation Of OCREVUS In Relapsing MS (RTTNews)
05.10.21	Genentech To Present New Data On Ocrevus In MS And Enspryng In NMOSD (RTTNews)
01.10.21	BioNTech Reports Initiation Of Phase 2 Trial With MRNA Cancer Vaccine Candidate (RTTNews)
30.09.21	Biotech Stocks Facing FDA Decision In October 2021 (RTTNews)
30.09.21	Regeneron's REGEN-COV Data Show Supportive Results In Patients Hospitalized With COVID-19 (RTTNews)
22.09.21	Roche Launches Three Respiratory Test Panels To Detect & Differentiate Common Respiratory Pathogens (RTTNews)
20.09.21	Genentech : Late-stage Trial Data Support Benefit Of Tecentriq In Early-stage Lung Cancer (RTTNews)
17.09.21	Roche Announces Positive CHMP Opinion For Gavreto In RET Fusion-positive Advanced NSCLC (RTTNews)
15.09.21	Roche Launches Digital Pathology Open Environment - Quick Facts (RTTNews)
15.09.21	Regeneron To Supply Additional 1.4 Mln Doses Of COVID-19 Therapy To U.S. (RTTNews)
09.09.21	Roche To Buy TIB Molbiol For Undisclosed Terms - Quick Facts (RTTNews)
07.09.21	Adaptimmune Inks JV With Genentech To Develop Allogeneic T-cell Therapies - Quick Facts (RTTNews)
07.09.21	NeuExcell, Spark Therapeutics To Collaborate To Develop Novel Gene Therapy For Huntington's Disease (RTTNews)
07.09.21	NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease (PR Newswire)
09.08.21	Genentech Says Phase III POLARIX Trial Of Polivy Plus R-CHP Meets Primary Endpoint (RTTNews)
05.08.21	Syros Pharma Reaches Deal With Roche On Colorectal Cancer Treatment (RTTNews)
02.08.21	Carrick Collaborates With Roche To Evaluate Samuraciclib Combination To Treat HR+ Breast Cancer (RTTNews)
29.07.21	FDA Accepts Application For Genentech's Eye Disease Drug Faricimab (RTTNews)
22.07.21	Roche H1 Profit Down; Confirms FY21 Outlook - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

03.04.25		Roche-Aktie schwächelt: Roche treibt Krebsdiagnostik voran - Forschungsrückschlag mit Ocrevus
05.02.25		Roche punktet bei der FDA: Grünes Licht für Susvimo gegen diabetesbedingte Erblindung - Aktie in Grün
25.06.24		Roche kann EU-Zulassung für Multiple-Sklerose-Mittel an Land ziehen - Aktie sinkt dennoch
10.06.24		Roche-Aktie dennoch tiefer: EU-Kommission lässt Lungenkrebsmedikament Alecensa zu
21.05.24		Roche-Aktie schwächer: Roche-Übernahme von LumiraDx in prüfung - Inavolisib erhält "Breakthrough Therapy"-Status
11.12.23		Roche-Aktie etwas fester: Roche legt Studiendaten zu Kadcyla, Hemlibra, Columvi und Lunsumio vor
02.02.23		Roche-Aktie schwächer: Roche erreicht 2022 Prognose - Umsatz- und Gewinnrückgang im neuen Jahr erwartet
27.12.22		Roche-Aktie leichter: FDA lässt Roches Lymphom-Behandlung Lunsumio zu

03.04.25

Roche-Aktie schwächelt: Roche treibt Krebsdiagnostik voran - Forschungsrückschlag mit Ocrevus

05.02.25

Roche punktet bei der FDA: Grünes Licht für Susvimo gegen diabetesbedingte Erblindung - Aktie in Grün

25.06.24

Roche kann EU-Zulassung für Multiple-Sklerose-Mittel an Land ziehen - Aktie sinkt dennoch

10.06.24

Roche-Aktie dennoch tiefer: EU-Kommission lässt Lungenkrebsmedikament Alecensa zu

21.05.24

Roche-Aktie schwächer: Roche-Übernahme von LumiraDx in prüfung - Inavolisib erhält "Breakthrough Therapy"-Status

11.12.23

Roche-Aktie etwas fester: Roche legt Studiendaten zu Kadcyla, Hemlibra, Columvi und Lunsumio vor

02.02.23

Roche-Aktie schwächer: Roche erreicht 2022 Prognose - Umsatz- und Gewinnrückgang im neuen Jahr erwartet

27.12.22

Roche-Aktie leichter: FDA lässt Roches Lymphom-Behandlung Lunsumio zu

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sonova Hldg	262.10	3.39 %	K V
Lonza Grp	584.80	2.38 %	K V
Logitech Intl	66.76	1.71 %	K V
Part Grp Hldg	1’114.00	1.41 %	K V
Swisscom	544.00	0.74 %	K V
ABB	45.07	0.04 %	K V
Novartis	90.91	-0.22 %	K V
Zurich Insur Gr	581.00	-0.34 %	K V
Roche Hldg G	257.60	-0.88 %	K V
Kuehne+Nagel Int	177.85	-3.24 %	K V

Roche Aktie VALOR 224184 / ISIN US7711951043

Nachrichten zu Roche Holding AG Sponsored American Deposit Receipt Repr 1/2 NVTGSh

Aktien Top/Flop

Roche Peer Group Nachrichten

Meistgelesene Nachrichten